Seroprevalence of rubella in pregnant women in Southern Morocco

Pan Afr Med J. 2020 Feb 10;35(Suppl 1):10. doi: 10.11604/pamj.supp.2020.35.1.18496. eCollection 2020.


Rubella is a generally benign but dangerous viral infection in early pregnancy, due to the teratogenic potential of the virus. Indeed, it causes spontaneous abortions, in-utero fetal death, premature labor and congenital malformations known as congenital rubella syndrome. The purpose of this study is to determine the immune status of rubella in pregnant women in southern Morocco. A prospective, multicentre study was conducted in 2017 for the detection of rubella IgG and IgM antibodies in 380 pregnant women aged 17 to 46 years, using the Architect i1000 chemiluminescent microparticle immunoassay. Eigthy for percent (84.7%) of women were seropositive. Ten percent of multiparous women remained seronegative despite recommendations for vaccination after delivery. Preventive measures against congenital rubella need to be strengthened, and vaccination is needed in non-immunized women. Vaccination awareness campaigns, especially among non-immunized multiparous women, remain essential.

Keywords: Pregnant women; rubella; seroprevalence.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Cross-Sectional Studies
  • Female
  • Humans
  • Immunization Programs
  • Infant, Newborn
  • Middle Aged
  • Morocco / epidemiology
  • Pregnancy
  • Pregnancy Complications, Infectious / blood
  • Pregnancy Complications, Infectious / epidemiology*
  • Pregnancy Outcome / epidemiology
  • Prospective Studies
  • Rubella / blood
  • Rubella / epidemiology*
  • Rubella / prevention & control
  • Rubella Syndrome, Congenital / blood
  • Rubella Syndrome, Congenital / epidemiology
  • Rubella Syndrome, Congenital / prevention & control
  • Seroepidemiologic Studies
  • Young Adult